Estrella Immunopharma
ESLA
ESLA
13 hedge funds and large institutions have $19.7M invested in Estrella Immunopharma in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
Holders
13
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.62M | |
| 2 | +$1.29M | |
| 3 | +$318K | |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$282K |
| 5 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$104K |
Top Sellers
| 1 | -$3.92M | |
| 2 | -$3.92M | |
| 3 | -$2.06M | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.77M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.76M |